<DOC>
	<DOCNO>NCT02915861</DOCNO>
	<brief_summary>This observational study patient scrub typhus ( rapid diagnostic test/quantitative polymerase chain reaction ( RDT/qPCR ) positive ) inoculation eschar present examination , recruit Chiangrai Prachanukroh Hospital , North Thailand . In study , aim : - Investigate relevant pathogen dissemination dynamic , early innate immune response , pathogen-host interaction scrub typhus use minimal set easily accessible sample ; inoculation eschar ( crust biopsy ) , whole blood - possible - lymph node fine-needle aspiration ( FNA ) . - Determine potential use inoculation eschar improve early diagnostics assess diversity human pathogenic strain ; evaluate non-invasive swabs scraping , well biopsies molecular diagnostics template . - Dissect underlying patho-biology associate inoculation eschar subgroup , include drain lymph node ; define spectrum infected cell via microscopy double-immune labeling ; determine cytokine RNA gene expression profile blood peripheral blood mononuclear cell ( PBMCs ) eschar sample .</brief_summary>
	<brief_title>Eschar Investigations Scrub Typhus</brief_title>
	<detailed_description>Scrub typhus patient recruit scrub typhus patient ( EXP ) arm study . There 3 sub-groups : - EXPa ( n=12 ) blood non-invasive eschar sample collect ( consent study , decline biopsy ) . - EXPb ( n=12 ) blood , non-invasive eschar sample , eschar biopsy collect ( consent study , drain lymph node ( LN ) inaccessible ) . - EXPc ( n=12 ) blood , non-invasive eschar sample , eschar biopsy , LN FNA collect ( consent study , drain LN accessible ) . Samples collect baseline ( ) 2 week ( blood ) . Control participant recruit scrub typhus control . - EXC ( n=12 ) healthy individual , attend hospital elective/minor surgery treatment minor skin injury , normally reside scrub typhus endemic region . Blood skin sample collect baseline .</detailed_description>
	<mesh_term>Typhus , Epidemic Louse-Borne</mesh_term>
	<mesh_term>Scrub Typhus</mesh_term>
	<criteria>Scrub Typhus Patients ( EXP ) inclusion criterion : Age ≥7 year old . Presentation hospital fever ≤14 day clinical suspicion typhus . Eschar observe examination . Scrub typhus RDT positive OT qPCR positive ( qPCR available local site time study initiation ) . Willingness participate study . Written inform consent obtain patient ( ≥18 year old ) , write informed assent participant ( ≥7 &lt; 18years old ) along write informed consent participant 's parent ( ) /legal guardian ( ) . Scrub Typhus Controls ( EXC ) inclusion criterion : Age ≥7 year old . Clinically well , attend elective/minor surgery treatment minor skin injury . Historical diagnosis scrub typhus ( RDT , serology , and/or PCR positivity ) 2 year ago live endemic area high risk previous exposure . Willingness participate study . Written inform consent obtain patient ( ≥18 year old ) write informed assent participant ( ≥7 &lt; 18years old ) along write informed consent participant 's parent ( ) /legal guardian ( ) . Scrub Typhus Patients ( EXP ) exclusion criterion : Current TB TB treatment ≤6 month ( contains OTeffective antimicrobial ) Documented HIV infection , use steroid , chemotherapy , immunosuppressant , herbal remedy contain steroid , and/or pregnancy Scrub Typhus Controls ( EXC ) exclusion criterion : Significant acute intercurrent illness time admission include fever &gt; 37.5˚C infection ( include TB ) require antibiotic Documented HIV infection , use steroid , chemotherapy , immunosuppressant , herbal remedy contain steroid , and/or pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>immune response</keyword>
	<keyword>vaccine</keyword>
</DOC>